Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0KR2J
|
||||
Former ID |
DAP000697
|
||||
Drug Name |
Entecavir
|
||||
Synonyms |
Baraclude; ETV; Entecavir hydrate; Entecavir monohydrate; BMS-200475; Baraclude (TN); Entecavir (INN); Entecavir (USAN); Entecavir hydrate (JAN); SQ-34676; 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1); 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one; 6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]; 9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | HBV infection [ICD9: 070.2-070.3; ICD10:B16, B18.0, B18.1] | Approved | [536361] | ||
Therapeutic Class |
Antiviral Agents
|
||||
Company |
Bristol-Myers Squibb
|
||||
Structure |
Download2D MOL |
||||
Formula |
C12H17N5O4
|
||||
Canonical SMILES |
C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N.O
|
||||
InChI |
1S/C12H15N5O3.H2O/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20;/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20);1H2/t6-,7-,8-;/m0./s1
|
||||
InChIKey |
YXPVEXCTPGULBZ-WQYNNSOESA-N
|
||||
CAS Number |
CAS 142217-69-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
17398002, 37101953, 49830936, 56391942, 57379683, 91749140, 99319526, 104253461, 118313779, 124757591, 125001900, 125164395, 126651626, 134222146, 136920321, 137129051, 137179356, 152034465, 162011500, 162183301, 163370951, 163908003, 164825059, 164833113, 172087090, 172440023, 174531851, 175265673, 180672743, 186013131, 196106268, 198991663, 210274904, 210280539, 223379249, 223398838, 226415922, 249739265, 251893489, 252110220, 252162333, 252316076
|
||||
SuperDrug ATC ID |
J05AF10
|
||||
Drug Resistance Mutation (DRM) | |||||
DRM | DRM Info | ||||
Target and Pathway | |||||
Target(s) | DNA polymerase/reverse transcriptase | Target Info | Modulator | [532700] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.